DaSilva, N. A., Barlock, B. J., Guha, P., Ghosh, C. C., Trebino, C. E., Camberg, J. L., . . . Rowley, D. C. (2021). Proteomic signatures of myeloid derived suppressor cells from liver and lung metastases reveal functional divergence and potential therapeutic targets. Cell death discovery, 7(1), 232-10. https://doi.org/10.1038/s41420-021-00621-x
Chicago-Zitierstil (17. Ausg.)DaSilva, Nicholas A., Benjamin J. Barlock, Prajna Guha, Chandra C. Ghosh, Catherine E. Trebino, Jodi L. Camberg, Steven C. Katz, und David C. Rowley. "Proteomic Signatures of Myeloid Derived Suppressor Cells from Liver and Lung Metastases Reveal Functional Divergence and Potential Therapeutic Targets." Cell Death Discovery 7, no. 1 (2021): 232-10. https://doi.org/10.1038/s41420-021-00621-x.
MLA-Zitierstil (9. Ausg.)DaSilva, Nicholas A., et al. "Proteomic Signatures of Myeloid Derived Suppressor Cells from Liver and Lung Metastases Reveal Functional Divergence and Potential Therapeutic Targets." Cell Death Discovery, vol. 7, no. 1, 2021, pp. 232-10, https://doi.org/10.1038/s41420-021-00621-x.